APO Research
Talk to an analyst

APO RESEARCH · REPORT

Canine Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Canine Vaccine Market Analysis and Forecast 2026-2032

26 December 2025196 pages

Choose your research edition.

Industry ResearchCanine Vaccine Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Canine Vaccine Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Canine Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Canine Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Canine Vaccine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Canine Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Canine Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Canine Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Canine Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Canine Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Canine Vaccine include Biogenesis Bago, Boehringer Ingelheim, Durvet, NeoTech, Virbac, Pfizer, Jilin Five-Star Animal Health, JINHE and Wuhan Keqian Biology, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Canine Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Canine Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Canine Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Canine Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Canine Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Canine Vaccine sales, projected growth trends, production technology, application and end-user industry.

Canine Vaccine Segment by Company

Biogenesis Bago

Boehringer Ingelheim

Durvet

NeoTech

Virbac

Pfizer

Jilin Five-Star Animal Health

JINHE

Wuhan Keqian Biology

SINOVAC

Elanco

Merck Animal Health

RuiPu Bio-Technology

Zoetis

CAHIC

Canine Vaccine Segment by Type

Core Vaccines

Non-Core Vaccines

Canine Vaccine Segment by Application

Puppies

Adult Dogs

Canine Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Canine Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Canine Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Canine Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Canine Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Canine Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Canine Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Canine Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Core Vaccines Major Manufacturers Table 3. Non-Core Vaccines Major Manufacturers Table 4. Global Canine Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Puppies Major Manufacturers Table 6. Adult Dogs Major Manufacturers Table 7. Canine Vaccine Industry Trends Table 8. Canine Vaccine Industry Drivers Table 9. Canine Vaccine Industry Opportunities and Challenges Table 10. Canine Vaccine Industry Restraints Table 11. Global Canine Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Canine Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Canine Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Canine Vaccine Revenue Market Share by Region (2021-2026) Table 15. Global Canine Vaccine Revenue Market Share by Region (2027-2032) Table 16. Global Canine Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Canine Vaccine Sales by Region (2021-2026) & (K Units) Table 18. Global Canine Vaccine Sales by Region (2027-2032) & (K Units) Table 19. Global Canine Vaccine Sales Market Share by Region (2021-2026) Table 20. Global Canine Vaccine Sales Market Share by Region (2027-2032) Table 21. Global Canine Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Canine Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Canine Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Canine Vaccine Sales Market Share by Manufacturers (2021-2026) Table 25. Global Canine Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Canine Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Canine Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Canine Vaccine Manufacturers, Product Type & Application Table 29. Global Canine Vaccine Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Canine Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Canine Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Canine Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Canine Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Canine Vaccine Revenue Market Share by Type (2021-2026) Table 36. Global Canine Vaccine Revenue Market Share by Type (2027-2032) Table 37. Global Canine Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Canine Vaccine Sales by Type (2021-2026) & (K Units) Table 39. Global Canine Vaccine Sales by Type (2027-2032) & (K Units) Table 40. Global Canine Vaccine Sales Market Share by Type (2021-2026) Table 41. Global Canine Vaccine Sales Market Share by Type (2027-2032) Table 42. Global Canine Vaccine Price by Type (2021-2026) & (US$/Unit) Table 43. Global Canine Vaccine Price by Type (2027-2032) & (US$/Unit) Table 44. Global Canine Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Canine Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Canine Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Canine Vaccine Revenue Market Share by Application (2021-2026) Table 48. Global Canine Vaccine Revenue Market Share by Application (2027-2032) Table 49. Global Canine Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Canine Vaccine Sales by Application (2021-2026) & (K Units) Table 51. Global Canine Vaccine Sales by Application (2027-2032) & (K Units) Table 52. Global Canine Vaccine Sales Market Share by Application (2021-2026) Table 53. Global Canine Vaccine Sales Market Share by Application (2027-2032) Table 54. Global Canine Vaccine Price by Application (2021-2026) & (US$/Unit) Table 55. Global Canine Vaccine Price by Application (2027-2032) & (US$/Unit) Table 56. Biogenesis Bago Company Information Table 57. Biogenesis Bago Business Overview Table 58. Biogenesis Bago Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Biogenesis Bago Canine Vaccine Product Portfolio Table 60. Biogenesis Bago Recent Development Table 61. Boehringer Ingelheim Company Information Table 62. Boehringer Ingelheim Business Overview Table 63. Boehringer Ingelheim Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Boehringer Ingelheim Canine Vaccine Product Portfolio Table 65. Boehringer Ingelheim Recent Development Table 66. Durvet Company Information Table 67. Durvet Business Overview Table 68. Durvet Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Durvet Canine Vaccine Product Portfolio Table 70. Durvet Recent Development Table 71. NeoTech Company Information Table 72. NeoTech Business Overview Table 73. NeoTech Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. NeoTech Canine Vaccine Product Portfolio Table 75. NeoTech Recent Development Table 76. Virbac Company Information Table 77. Virbac Business Overview Table 78. Virbac Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Virbac Canine Vaccine Product Portfolio Table 80. Virbac Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Pfizer Canine Vaccine Product Portfolio Table 85. Pfizer Recent Development Table 86. Jilin Five-Star Animal Health Company Information Table 87. Jilin Five-Star Animal Health Business Overview Table 88. Jilin Five-Star Animal Health Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Jilin Five-Star Animal Health Canine Vaccine Product Portfolio Table 90. Jilin Five-Star Animal Health Recent Development Table 91. JINHE Company Information Table 92. JINHE Business Overview Table 93. JINHE Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. JINHE Canine Vaccine Product Portfolio Table 95. JINHE Recent Development Table 96. Wuhan Keqian Biology Company Information Table 97. Wuhan Keqian Biology Business Overview Table 98. Wuhan Keqian Biology Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Wuhan Keqian Biology Canine Vaccine Product Portfolio Table 100. Wuhan Keqian Biology Recent Development Table 101. SINOVAC Company Information Table 102. SINOVAC Business Overview Table 103. SINOVAC Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. SINOVAC Canine Vaccine Product Portfolio Table 105. SINOVAC Recent Development Table 106. Elanco Company Information Table 107. Elanco Business Overview Table 108. Elanco Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Elanco Canine Vaccine Product Portfolio Table 110. Elanco Recent Development Table 111. Merck Animal Health Company Information Table 112. Merck Animal Health Business Overview Table 113. Merck Animal Health Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Merck Animal Health Canine Vaccine Product Portfolio Table 115. Merck Animal Health Recent Development Table 116. RuiPu Bio-Technology Company Information Table 117. RuiPu Bio-Technology Business Overview Table 118. RuiPu Bio-Technology Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. RuiPu Bio-Technology Canine Vaccine Product Portfolio Table 120. RuiPu Bio-Technology Recent Development Table 121. Zoetis Company Information Table 122. Zoetis Business Overview Table 123. Zoetis Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Zoetis Canine Vaccine Product Portfolio Table 125. Zoetis Recent Development Table 126. CAHIC Company Information Table 127. CAHIC Business Overview Table 128. CAHIC Canine Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. CAHIC Canine Vaccine Product Portfolio Table 130. CAHIC Recent Development Table 131. North America Canine Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 132. North America Canine Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 133. North America Canine Vaccine Sales by Type (2021-2026) & (K Units) Table 134. North America Canine Vaccine Sales by Type (2027-2032) & (K Units) Table 135. North America Canine Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 136. North America Canine Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 137. North America Canine Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 138. North America Canine Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 139. North America Canine Vaccine Sales by Application (2021-2026) & (K Units) Table 140. North America Canine Vaccine Sales by Application (2027-2032) & (K Units) Table 141. North America Canine Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 142. North America Canine Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 143. North America Canine Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. North America Canine Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. North America Canine Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. North America Canine Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 147. North America Canine Vaccine Sales by Country (2021-2026) & (K Units) Table 148. North America Canine Vaccine Sales by Country (2027-2032) & (K Units) Table 149. North America Canine Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 150. North America Canine Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 151. United States Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 152. Canada Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 153. Mexico Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 154. Europe Canine Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 155. Europe Canine Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 156. Europe Canine Vaccine Sales by Type (2021-2026) & (K Units) Table 157. Europe Canine Vaccine Sales by Type (2027-2032) & (K Units) Table 158. Europe Canine Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 159. Europe Canine Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 160. Europe Canine Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 161. Europe Canine Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 162. Europe Canine Vaccine Sales by Application (2021-2026) & (K Units) Table 163. Europe Canine Vaccine Sales by Application (2027-2032) & (K Units) Table 164. Europe Canine Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 165. Europe Canine Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 166. Europe Canine Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. Europe Canine Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 168. Europe Canine Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 169. Europe Canine Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 170. Europe Canine Vaccine Sales by Country (2021-2026) & (K Units) Table 171. Europe Canine Vaccine Sales by Country (2027-2032) & (K Units) Table 172. Europe Canine Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 173. Europe Canine Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 174. Germany Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 175. France Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 176. U.K. Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 177. Italy Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 178. Russia Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 179. Spain Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 180. Netherlands Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 181. Switzerland Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 182. Sweden Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 183. Poland Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 184. China Canine Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 185. China Canine Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 186. China Canine Vaccine Sales by Type (2021-2026) & (K Units) Table 187. China Canine Vaccine Sales by Type (2027-2032) & (K Units) Table 188. China Canine Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 189. China Canine Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 190. China Canine Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 191. China Canine Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 192. China Canine Vaccine Sales by Application (2021-2026) & (K Units) Table 193. China Canine Vaccine Sales by Application (2027-2032) & (K Units) Table 194. China Canine Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 195. China Canine Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 196. Asia Canine Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 197. Asia Canine Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 198. Asia Canine Vaccine Sales by Type (2021-2026) & (K Units) Table 199. Asia Canine Vaccine Sales by Type (2027-2032) & (K Units) Table 200. Asia Canine Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 201. Asia Canine Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 202. Asia Canine Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 203. Asia Canine Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 204. Asia Canine Vaccine Sales by Application (2021-2026) & (K Units) Table 205. Asia Canine Vaccine Sales by Application (2027-2032) & (K Units) Table 206. Asia Canine Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 207. Asia Canine Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 208. Asia Canine Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 209. Asia Canine Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 210. Asia Canine Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 211. Asia Canine Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 212. Asia Canine Vaccine Sales by Country (2021-2026) & (K Units) Table 213. Asia Canine Vaccine Sales by Country (2027-2032) & (K Units) Table 214. Asia Canine Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 215. Asia Canine Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 216. Japan Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 217. South Korea Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 218. India Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 219. Australia Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 220. Taiwan Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 221. Southeast Asia Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 222. SAMEA Canine Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 223. SAMEA Canine Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 224. SAMEA Canine Vaccine Sales by Type (2021-2026) & (K Units) Table 225. SAMEA Canine Vaccine Sales by Type (2027-2032) & (K Units) Table 226. SAMEA Canine Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 227. SAMEA Canine Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 228. SAMEA Canine Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 229. SAMEA Canine Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 230. SAMEA Canine Vaccine Sales by Application (2021-2026) & (K Units) Table 231. SAMEA Canine Vaccine Sales by Application (2027-2032) & (K Units) Table 232. SAMEA Canine Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 233. SAMEA Canine Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 234. SAMEA Canine Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 235. SAMEA Canine Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 236. SAMEA Canine Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 237. SAMEA Canine Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 238. SAMEA Canine Vaccine Sales by Country (2021-2026) & (K Units) Table 239. SAMEA Canine Vaccine Sales by Country (2027-2032) & (K Units) Table 240. SAMEA Canine Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 241. SAMEA Canine Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 242. Brazil Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 243. Argentina Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 244. Chile Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 245. Colombia Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 246. Peru Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 247. Saudi Arabia Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 248. Israel Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 249. UAE Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 250. Turkey Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 251. Iran Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 252. Egypt Canine Vaccine Revenue (2021-2032) & (US$ Million) Table 253. Key Raw Materials Table 254. Raw Materials Key Suppliers Table 255. Canine Vaccine Distributors List Table 256. Canine Vaccine Customers List Table 257. Research Programs/Design for This Report Table 258. Authors List of This Report Table 259. Secondary Sources Table 260. Primary Sources List of Figures Figure 1. Canine Vaccine Image Figure 2. Global Canine Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Canine Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Core Vaccines Image Figure 5. Non-Core Vaccines Image Figure 6. Global Canine Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Canine Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Puppies Image Figure 9. Adult Dogs Image Figure 10. Global Canine Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Canine Vaccine Revenue (2021-2032) & (US$ Million) Figure 12. Global Canine Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Canine Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Canine Vaccine Revenue Market Share by Region (2021-2032) Figure 15. Global Canine Vaccine Sales (2021-2032) & (K Units) Figure 16. Global Canine Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Canine Vaccine Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Canine Vaccine Sales YoY (2021-2032) & (K Units) Figure 19. Europe Canine Vaccine Sales YoY (2021-2032) & (K Units) Figure 20. China Canine Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Canine Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Canine Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. Global Canine Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Canine Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Canine Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Canine Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Canine Vaccine Revenue Market Share by Type (2021-2032) Figure 29. Global Canine Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Canine Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Canine Vaccine Sales Market Share by Type (2021-2032) Figure 32. Global Canine Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Canine Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Canine Vaccine Revenue Market Share by Application (2021-2032) Figure 35. Global Canine Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Canine Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Canine Vaccine Sales Market Share by Application (2021-2032) Figure 38. North America Canine Vaccine Revenue Share by Type (2021-2032) Figure 39. North America Canine Vaccine Sales Share by Type (2021-2032) Figure 40. North America Canine Vaccine Revenue Share by Application (2021-2032) Figure 41. North America Canine Vaccine Sales Share by Application (2021-2032) Figure 42. North America Canine Vaccine Revenue Share by Country (2021-2032) Figure 43. North America Canine Vaccine Sales Share by Country (2021-2032) Figure 44. Europe Canine Vaccine Revenue Share by Type (2021-2032) Figure 45. Europe Canine Vaccine Sales Share by Type (2021-2032) Figure 46. Europe Canine Vaccine Revenue Share by Application (2021-2032) Figure 47. Europe Canine Vaccine Sales Share by Application (2021-2032) Figure 48. Europe Canine Vaccine Revenue Share by Country (2021-2032) Figure 49. Europe Canine Vaccine Sales Share by Country (2021-2032) Figure 50. China Canine Vaccine Revenue Share by Type (2021-2032) Figure 51. China Canine Vaccine Sales Share by Type (2021-2032) Figure 52. China Canine Vaccine Revenue Share by Application (2021-2032) Figure 53. China Canine Vaccine Sales Share by Application (2021-2032) Figure 54. Asia Canine Vaccine Revenue Share by Type (2021-2032) Figure 55. Asia Canine Vaccine Sales Share by Type (2021-2032) Figure 56. Asia Canine Vaccine Revenue Share by Application (2021-2032) Figure 57. Asia Canine Vaccine Sales Share by Application (2021-2032) Figure 58. Asia Canine Vaccine Revenue Share by Country (2021-2032) Figure 59. Asia Canine Vaccine Sales Share by Country (2021-2032) Figure 60. SAMEA Canine Vaccine Revenue Share by Type (2021-2032) Figure 61. SAMEA Canine Vaccine Sales Share by Type (2021-2032) Figure 62. SAMEA Canine Vaccine Revenue Share by Application (2021-2032) Figure 63. SAMEA Canine Vaccine Sales Share by Application (2021-2032) Figure 64. SAMEA Canine Vaccine Revenue Share by Country (2021-2032) Figure 65. SAMEA Canine Vaccine Sales Share by Country (2021-2032) Figure 66. Canine Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Canine Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Core Vaccines
  • Non-Core Vaccines
Applications
  • Puppies
  • Adult Dogs
Companies covered
  • Biogenesis Bago
  • Boehringer Ingelheim
  • Durvet
  • NeoTech
  • Virbac
  • Pfizer
  • Jilin Five-Star Animal Health
  • JINHE
  • Wuhan Keqian Biology
  • SINOVAC
  • Elanco
  • Merck Animal Health
  • RuiPu Bio-Technology
  • Zoetis
  • CAHIC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Canine Vaccine Market by Type
  3. 1.2.1 Global Canine Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Core Vaccines
  5. 1.2.3 Non-Core Vaccines
  6. 1.3 Canine Vaccine Market by Application
  7. 1.3.1 Global Canine Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Puppies
  9. 1.3.3 Adult Dogs
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Canine Vaccine Market Dynamics
  1. 2.1 Canine Vaccine Industry Trends
  2. 2.2 Canine Vaccine Industry Drivers
  3. 2.3 Canine Vaccine Industry Opportunities and Challenges
  4. 2.4 Canine Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Canine Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Canine Vaccine Revenue by Region
  3. 3.2.1 Global Canine Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Canine Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Canine Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Canine Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Canine Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Canine Vaccine Sales by Region
  9. 3.4.1 Global Canine Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Canine Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Canine Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Canine Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Canine Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Canine Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Canine Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Canine Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Canine Vaccine Sales by Manufacturers
  6. 4.2.1 Global Canine Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Canine Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Canine Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Canine Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Canine Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Canine Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Canine Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Canine Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Canine Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Canine Vaccine Tier 1, Tier 2, and Tier 3
5 Canine Vaccine Market by Type
  1. 5.1 Global Canine Vaccine Revenue by Type
  2. 5.1.1 Global Canine Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Canine Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Canine Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Canine Vaccine Sales by Type
  6. 5.2.1 Global Canine Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Canine Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Canine Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Canine Vaccine Price by Type
6 Canine Vaccine Market by Application
  1. 6.1 Global Canine Vaccine Revenue by Application
  2. 6.1.1 Global Canine Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Canine Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Canine Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Canine Vaccine Sales by Application
  6. 6.2.1 Global Canine Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Canine Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Canine Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Canine Vaccine Price by Application
7 Company Profiles
  1. 7.1 Biogenesis Bago
  2. 7.1.1 Biogenesis Bago Company Information
  3. 7.1.2 Biogenesis Bago Business Overview
  4. 7.1.3 Biogenesis Bago Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Biogenesis Bago Canine Vaccine Product Portfolio
  6. 7.1.5 Biogenesis Bago Recent Developments
  7. 7.2 Boehringer Ingelheim
  8. 7.2.1 Boehringer Ingelheim Company Information
  9. 7.2.2 Boehringer Ingelheim Business Overview
  10. 7.2.3 Boehringer Ingelheim Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Boehringer Ingelheim Canine Vaccine Product Portfolio
  12. 7.2.5 Boehringer Ingelheim Recent Developments
  13. 7.3 Durvet
  14. 7.3.1 Durvet Company Information
  15. 7.3.2 Durvet Business Overview
  16. 7.3.3 Durvet Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Durvet Canine Vaccine Product Portfolio
  18. 7.3.5 Durvet Recent Developments
  19. 7.4 NeoTech
  20. 7.4.1 NeoTech Company Information
  21. 7.4.2 NeoTech Business Overview
  22. 7.4.3 NeoTech Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 NeoTech Canine Vaccine Product Portfolio
  24. 7.4.5 NeoTech Recent Developments
  25. 7.5 Virbac
  26. 7.5.1 Virbac Company Information
  27. 7.5.2 Virbac Business Overview
  28. 7.5.3 Virbac Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Virbac Canine Vaccine Product Portfolio
  30. 7.5.5 Virbac Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Canine Vaccine Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 Jilin Five-Star Animal Health
  38. 7.7.1 Jilin Five-Star Animal Health Company Information
  39. 7.7.2 Jilin Five-Star Animal Health Business Overview
  40. 7.7.3 Jilin Five-Star Animal Health Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Jilin Five-Star Animal Health Canine Vaccine Product Portfolio
  42. 7.7.5 Jilin Five-Star Animal Health Recent Developments
  43. 7.8 JINHE
  44. 7.8.1 JINHE Company Information
  45. 7.8.2 JINHE Business Overview
  46. 7.8.3 JINHE Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 JINHE Canine Vaccine Product Portfolio
  48. 7.8.5 JINHE Recent Developments
  49. 7.9 Wuhan Keqian Biology
  50. 7.9.1 Wuhan Keqian Biology Company Information
  51. 7.9.2 Wuhan Keqian Biology Business Overview
  52. 7.9.3 Wuhan Keqian Biology Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Wuhan Keqian Biology Canine Vaccine Product Portfolio
  54. 7.9.5 Wuhan Keqian Biology Recent Developments
  55. 7.10 SINOVAC
  56. 7.10.1 SINOVAC Company Information
  57. 7.10.2 SINOVAC Business Overview
  58. 7.10.3 SINOVAC Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 SINOVAC Canine Vaccine Product Portfolio
  60. 7.10.5 SINOVAC Recent Developments
  61. 7.11 Elanco
  62. 7.11.1 Elanco Company Information
  63. 7.11.2 Elanco Business Overview
  64. 7.11.3 Elanco Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Elanco Canine Vaccine Product Portfolio
  66. 7.11.5 Elanco Recent Developments
  67. 7.12 Merck Animal Health
  68. 7.12.1 Merck Animal Health Company Information
  69. 7.12.2 Merck Animal Health Business Overview
  70. 7.12.3 Merck Animal Health Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Merck Animal Health Canine Vaccine Product Portfolio
  72. 7.12.5 Merck Animal Health Recent Developments
  73. 7.13 RuiPu Bio-Technology
  74. 7.13.1 RuiPu Bio-Technology Company Information
  75. 7.13.2 RuiPu Bio-Technology Business Overview
  76. 7.13.3 RuiPu Bio-Technology Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 RuiPu Bio-Technology Canine Vaccine Product Portfolio
  78. 7.13.5 RuiPu Bio-Technology Recent Developments
  79. 7.14 Zoetis
  80. 7.14.1 Zoetis Company Information
  81. 7.14.2 Zoetis Business Overview
  82. 7.14.3 Zoetis Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Zoetis Canine Vaccine Product Portfolio
  84. 7.14.5 Zoetis Recent Developments
  85. 7.15 CAHIC
  86. 7.15.1 CAHIC Company Information
  87. 7.15.2 CAHIC Business Overview
  88. 7.15.3 CAHIC Canine Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 CAHIC Canine Vaccine Product Portfolio
  90. 7.15.5 CAHIC Recent Developments
8 North America
  1. 8.1 North America Canine Vaccine Market Size by Type
  2. 8.1.1 North America Canine Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Canine Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Canine Vaccine Price by Type (2021-2032)
  5. 8.2 North America Canine Vaccine Market Size by Application
  6. 8.2.1 North America Canine Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Canine Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Canine Vaccine Price by Application (2021-2032)
  9. 8.3 North America Canine Vaccine Market Size by Country
  10. 8.3.1 North America Canine Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Canine Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Canine Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Canine Vaccine Market Size by Type
  2. 9.1.1 Europe Canine Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Canine Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Canine Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Canine Vaccine Market Size by Application
  6. 9.2.1 Europe Canine Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Canine Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Canine Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Canine Vaccine Market Size by Country
  10. 9.3.1 Europe Canine Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Canine Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Canine Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Canine Vaccine Market Size by Type
  2. 10.1.1 China Canine Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Canine Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Canine Vaccine Price by Type (2021-2032)
  5. 10.2 China Canine Vaccine Market Size by Application
  6. 10.2.1 China Canine Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Canine Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Canine Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Canine Vaccine Market Size by Type
  2. 11.1.1 Asia Canine Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Canine Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Canine Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Canine Vaccine Market Size by Application
  6. 11.2.1 Asia Canine Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Canine Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Canine Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Canine Vaccine Market Size by Country
  10. 11.3.1 Asia Canine Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Canine Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Canine Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Canine Vaccine Market Size by Type
  2. 12.1.1 SAMEA Canine Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Canine Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Canine Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Canine Vaccine Market Size by Application
  6. 12.2.1 SAMEA Canine Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Canine Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Canine Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Canine Vaccine Market Size by Country
  10. 12.3.1 SAMEA Canine Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Canine Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Canine Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Canine Vaccine Value Chain Analysis
  2. 13.1.1 Canine Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Canine Vaccine Production Mode & Process
  6. 13.2 Canine Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Canine Vaccine Distributors
  9. 13.2.3 Canine Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst